Reactivation of p53: from peptides to small molecules.

Abstract:

:Approximately 27 million people are living with a tumour in which the tumour suppressing activity of p53 has been inactivated. In half of these tumours, p53 itself is not mutated but the pathway is partially abrogated. Mechanisms include the overexpression of negative regulators of p53, such as MDM2 and MDM4, and deletion or epigenetic inactivation of the positive regulators of p53 such as ARF. In the other half of tumours, in which p53 is inactivated, p53 is mutated and ∼95% of these mutations lie in the core DNA-binding domain, which reflects the key role of p53 as a transcriptional activator. Reactivation of the tumour suppressive properties of p53 is a key therapeutic goal, and the use of peptides in p53 research has led directly to the development of two alternative small molecule approaches: stabilization of mutant p53 to rescue its DNA-binding activity and inhibition of MDM2 or MDM4.

journal_name

Trends Pharmacol Sci

authors

Brown CJ,Cheok CF,Verma CS,Lane DP

doi

10.1016/j.tips.2010.11.004

subject

Has Abstract

pub_date

2011-01-01 00:00:00

pages

53-62

issue

1

eissn

0165-6147

issn

1873-3735

pii

S0165-6147(10)00205-1

journal_volume

32

pub_type

杂志文章,评审
  • Epoxyeicosatrienoic Acid as Therapy for Diabetic and Ischemic Cardiomyopathy.

    abstract::Cardiovascular disease remains the leading cause of death worldwide. Among many potential targets for pharmacological intervention, a promising strategy involves epoxyeicosatrienoic acid (EET) and soluble epoxide hydroxylase (sEH) inhibition. sEH is the enzyme that converts EET to its less potent metabolite; therefore...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2016.08.001

    authors: Romashko M,Schragenheim J,Abraham NG,McClung JA

    更新日期:2016-11-01 00:00:00

  • NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?

    abstract::Non-steroidal anti-inflammatory drugs (NSAIDs) have been considered for treatment and prevention of Alzheimer's disease (AD) for more than two decades. Biochemical markers in the brains of individuals with AD suggest that inflammation might be a driving cause of the disease that can be suppressed by drug treatment. In...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2007.09.004

    authors: Weggen S,Rogers M,Eriksen J

    更新日期:2007-10-01 00:00:00

  • Small airways: an important but neglected target in the treatment of obstructive airway diseases.

    abstract::Changes in the structure and function of the small airways (<2mm diameter) are now recognized to play a major role in airflow limitation in both chronic obstructive pulmonary disease (COPD) and severe asthma. Increased thickness of the small airway wall causes lumenal narrowing, which can be further occluded by mucus ...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2008.04.003

    authors: Sturton G,Persson C,Barnes PJ

    更新日期:2008-07-01 00:00:00

  • Neurobiology and treatment of Parkinson's disease.

    abstract::Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease and is an important cause of chronic disability. Numerous important advances have been made in our understanding of the aetiopathogenesis, pathology and clinical phenomenology of this disease, and these have underpi...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2008.10.005

    authors: Schapira AH

    更新日期:2009-01-01 00:00:00

  • Cooperativity Has Empirical and Ultimate Levels of Explanation.

    abstract::Controversy over the meaning of pharmacological parameters often arises because of a lack of appreciation of different hierarchical levels of analysis. In a recent letter in Trends in Pharmacological Sciences, Zhang and Kavana [1] concluded that my two-state model for allosterism lacks cooperativity, even though Figur...

    journal_title:Trends in pharmacological sciences

    pub_type: 评论,信件

    doi:10.1016/j.tips.2016.06.001

    authors: Ehlert FJ

    更新日期:2016-08-01 00:00:00

  • Pharmacological inhibitors of MAPK pathways.

    abstract::Mitogen-activated protein kinases [MAPKs, also called extracellular signal-regulated kinases (ERKs)] are constituents of numerous signal transduction pathways, and are activated by protein kinase cascades. Intense efforts are under way to develop and evaluate compounds that target components of MAPK pathways. In this ...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/s0165-6147(00)01865-4

    authors: English JM,Cobb MH

    更新日期:2002-01-01 00:00:00

  • Updating Neuroimmune Targets in Central Nervous System Dysfunction.

    abstract::Disorders of the central nervous system (CNS) have many etiologies compounded by limited options for treatment. The lack of successful treatments for these disorders stems from the difficulty of gaining effective access to the CNS through the blood-brain barrier, and the irreplaceable nature of neurons. Here, we revie...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2019.04.013

    authors: Valente LA,Begg LR,Filiano AJ

    更新日期:2019-07-01 00:00:00

  • Deep Learning to Therapeutically Target Unreported Complexes.

    abstract::The disruption of large protein-protein (PP) interfaces remains a challenge in targeted therapy. Designing drugs that compete with binding partners is daunting, especially when the structure of the protein complex is unknown. To address the problem we propose a deep protein databank (PDB) learning platform to discover...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章

    doi:10.1016/j.tips.2019.04.009

    authors: Fernández A

    更新日期:2019-08-01 00:00:00

  • Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors.

    abstract::It is generally accepted that seven-transmembrane receptors have the capacity to regulate cellular signaling systems in the absence of occupancy by a ligand (i.e. the receptors display constitutive activity). Drugs can increase (agonists), decrease (inverse agonists) or not change (antagonists) receptor activity towar...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2005.10.008

    authors: Berg KA,Harvey JA,Spampinato U,Clarke WP

    更新日期:2005-12-01 00:00:00

  • Similarities between the Yin/Yang Doctrine and Hormesis in Toxicology and Pharmacology.

    abstract::Hormesis is a generalizable dose-response relationship characterized by low-dose stimulation and high-dose inhibition. Despite debate over this biphasic dose-response curve, hormesis is challenging central beliefs in the evaluation of chemicals or drugs and has influenced biological model selection, concentration rang...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2020.05.004

    authors: Sun H,Calabrese EJ,Lin Z,Lian B,Zhang X

    更新日期:2020-08-01 00:00:00

  • Recent findings on the mode of action of laxatives: the role of platelet activating factor and nitric oxide.

    abstract::Platelet activating factor (PAF) is a phospholipid mediator of inflammation and stimulates anion secretion in animals and in isolated preparations of human colon. Nitric oxide (NO), synthesized from the amino acid L-arginine, is an important enteric inhibitory neurotransmitter. In addition, NO-donating compounds stimu...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/s0165-6147(98)01249-8

    authors: Izzo AA,Gaginella TS,Mascolo N,Capasso F

    更新日期:1998-10-01 00:00:00

  • Ca2+ channel beta-subunits: structural insights AID our understanding.

    abstract::It has taken 17 years from the first identification of a voltage-gated Ca2+ channel (CaV) beta-subunit as a band on a gel following purification of skeletal muscle dihydropyridine (DHP) receptors in 1987 to the publication of key information on the structures of Ca2+ channel beta-subunits. Three recent X-ray crystallo...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2004.10.008

    authors: Richards MW,Butcher AJ,Dolphin AC

    更新日期:2004-12-01 00:00:00

  • Cancer and Microenvironment Plasticity: Double-Edged Swords in Metastasis.

    abstract::Cancer initiates at one site (primary tumor) and, in most cases, spreads to other distant organs (metastasis). During the multistep process of metastasis, primary tumor cells acquire cellular and phenotypic plasticity to survive and thrive in different environments. Moreover, cancer cells also utilize and educate micr...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2019.04.005

    authors: Zhuang X,Zhang H,Hu G

    更新日期:2019-06-01 00:00:00

  • Biological and clinical implications of the MTHFR C677T polymorphism.

    abstract::The enzyme methylenetetrahydrofolate reductase (MTHFR) directs folate species either to DNA synthesis or to homocysteine (Hcy) remethylation. The common MTHFR C677T polymorphism affects the activity of the enzyme and hence folate distribution. Under conditions of impaired folate status, the homozygous TT genotype has ...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/s0165-6147(00)01675-8

    authors: Ueland PM,Hustad S,Schneede J,Refsum H,Vollset SE

    更新日期:2001-04-01 00:00:00

  • Techniques: fruit flies as models for neuropharmacological research.

    abstract::An unlikely animal model is gaining popularity in neuropharmacological research: the 2-mm fruit fly (Drosophila melanogaster). Drugs have been administered to adult flies in their food and, more recently, via gasses and injections. Pharmacological tools have introduced behavioral alterations in Drosophila reminiscent ...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/s0165-6147(02)00004-4

    authors: Manev H,Dimitrijevic N,Dzitoyeva S

    更新日期:2003-01-01 00:00:00

  • How important is intestinal cytochrome P450 3A metabolism?

    abstract::Cytochrome P450 3A (CYP3A) enzymes metabolize a wide variety of xenobiotics including many drugs. Because CYP3A is localized in both the liver and intestine, it can make a major contribution to the presystemic elimination of substrate drugs after oral administration ('first-pass metabolism'). However, assessments of t...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章

    doi:10.1016/j.tips.2009.02.003

    authors: van Herwaarden AE,van Waterschoot RA,Schinkel AH

    更新日期:2009-05-01 00:00:00

  • Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics.

    abstract::Thiol-based drugs are considered as mucolytics because they decrease the viscosity and mostly decrease the elasticity of bronchial secretions by reducing disulfide bonds in proteins. However, they can also act as antioxidant drugs directly through free sulfhydryl groups that serve as a source of reducing equivalents, ...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章

    doi:10.1016/j.tips.2019.04.015

    authors: Cazzola M,Calzetta L,Page C,Rogliani P,Matera MG

    更新日期:2019-07-01 00:00:00

  • Drugs of abuse: anatomy, pharmacology and function of reward pathways.

    abstract::Drugs of abuse are very powerful reinforcers, and even in conditions of limited access (where the organism is not dependent) these drugs will motivate high rates of operant responding. This presumed hedonic property and the drugs' neuropharmacological specificity provide a means of studying the neuropharmacology and n...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/0165-6147(92)90060-j

    authors: Koob GF

    更新日期:1992-05-01 00:00:00

  • Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines.

    abstract::NMDA and non-NMDA (AMPA/kainate) antagonists have potential in the treatment of a diverse group of neurological disorders associated with excessive activation of excitatory amino acid receptors. Here Michael Rogawski reviews recent progress in the development of therapeutically useful NMDA receptor channel blockers an...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/0165-6147(93)90005-5

    authors: Rogawski MA

    更新日期:1993-09-01 00:00:00

  • Structural insights into adrenergic receptor function and pharmacology.

    abstract::It has been over 50years since Sir James Black developed the first beta adrenergic receptor (βAR) blocker to treat heart disease. At that time, the concept of cell surface receptors was relatively new and not widely accepted, and most of the tools currently used to characterize plasma membrane receptors had not been d...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2011.02.005

    authors: Kobilka BK

    更新日期:2011-04-01 00:00:00

  • Anti-inflammatory actions of steroids: molecular mechanisms.

    abstract::Glucocorticosteroids are highly effective in controlling inflammation and the molecular mechanisms involved are now becoming clear. Activation of glucocorticoid receptors results in increased or decreased transcription of a number of genes involved in the inflammatory process. Of particular importance is the repressio...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/0165-6147(93)90184-l

    authors: Barnes PJ,Adcock I

    更新日期:1993-12-01 00:00:00

  • Diverse functions of muscarinic acetylcholine receptor subtypes.

    abstract::Muscarinic acetylcholine receptor subtypes m1, m3 and m5 couple strongly to phosphatidylinositol turnover and hence to intracellular Ca2+ concentration via pertussis toxin (PTX) sensitive and insensitive G proteins. The m2 and m4 muscarinic receptor subtypes strongly inhibit adenylyl cyclase production via PTX sensiti...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:

    authors: Lechleiter J,Peralta E,Clapham D

    更新日期:1989-12-01 00:00:00

  • Techniques: reporter mice - a new way to look at drug action.

    abstract::During the past decade remarkable progress in molecular genetics and the possibility of manipulating cells so that the expression of genes can directly 'report' on drug activity has produced major changes in drug development strategies. The recent description and pharmacological validation of reporter mice for in vivo...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2004.04.007

    authors: Maggi A,Ottobrini L,Biserni A,Lucignani G,Ciana P

    更新日期:2004-06-01 00:00:00

  • Clodronate: A Vesicular ATP Release Blocker.

    abstract::Clodronate is a first-generation bisphosphonate used worldwide for antiresorptive therapy for osteoporosis. Although clodronate is analgesic in nature, its mechanism and efficacy were unknown for some time. Recently, clodronate was identified as a selective and potent inhibitor for vesicular nucleotide transporter (VN...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2017.10.007

    authors: Moriyama Y,Nomura M

    更新日期:2018-01-01 00:00:00

  • Your bleeding heart: lessons from low tissue factor expression in mice.

    abstract::Tissue factor (TF) is the cellular receptor and cofactor for blood coagulation factor VII (FVII). Exposure of flowing blood to cells that express TF leads to the initiation of blood coagulation. A recent study of mice expressing low levels of TF has demonstrated the importance of TF and FVII in maintaining adequate ha...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/S0165-6147(03)00121-4

    authors: McVey JH

    更新日期:2003-06-01 00:00:00

  • New genome-wide methods bring more power to yeast as a model organism.

    abstract::Recent developments in genetic research using Saccharomyces cerevisiae have provided rapid new methods for identifying the genes that control cellular responses to treatment with a wide variety of agents, including chemicals and radiation. This significantly increases the power of yeast as a model system for studying ...

    journal_title:Trends in pharmacological sciences

    pub_type: 新闻

    doi:10.1016/s0165-6147(02)02082-5

    authors: Game JC

    更新日期:2002-10-01 00:00:00

  • Folding Underlies Bidirectional Role of GPR37/Pael-R in Parkinson Disease.

    abstract::Since conformational flexibility, which is required for the function of a protein, comes at the expense of structural stability, many proteins, including G-protein-coupled receptors (GPCRs), are under constant risk of misfolding and aggregation. In this regard GPR37 (also named PAEL-R and ETBR-LP-1) takes a prominent ...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2017.05.006

    authors: Leinartaité L,Svenningsson P

    更新日期:2017-08-01 00:00:00

  • Control of transmitter release from the motor nerve by presynaptic nicotinic and muscarinic autoreceptors.

    abstract::Until recently, release studies have failed to indicate the existence of autoreceptors on motor nerves. Ignaz Wessler now reports on a refinement of the technique - the measurement of newly synthesized [3H]acetylcholine released from the phrenic nerve - which provides clear evidence in support of release-modulating au...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/0165-6147(89)90208-3

    authors: Wessler I

    更新日期:1989-03-01 00:00:00

  • Identifying Missing Biosynthesis Enzymes of Plant Natural Products.

    abstract::Elucidating plant-specialized biosynthetic pathways has always constituted a laborious task, notably for natural products with high pharmaceutical values. Here, we discuss emerging omics-based strategies that facilitate the identification of genes from these complex metabolic pathways, paving the way to engineered sup...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章

    doi:10.1016/j.tips.2019.12.006

    authors: Dugé de Bernonville T,Papon N,Clastre M,O'Connor SE,Courdavault V

    更新日期:2020-03-01 00:00:00

  • Does the pharmacology of oxycodone justify its increasing use as an analgesic?

    abstract::Oxycodone is a semisynthetic opioid analgesic that is increasingly used for the treatment of acute, cancer, and chronic non-malignant pain. Oxycodone was synthesized in 1917 but its pharmacological properties were not thoroughly studied until recently. Oxycodone is a fairly selective μ-opioid receptor agonist, but the...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2013.02.001

    authors: Olkkola KT,Kontinen VK,Saari TI,Kalso EA

    更新日期:2013-04-01 00:00:00